PKC-IN-6 is a selective inhibitor of protein kinase C-α (PKC-α) with an IC 50 of 240 μM. PKC-IN-6 shows no inhibitory activity against PKC-δ , PKA or EGF-R tyrosine kinase. PKC-IN-6 can be used in research related to bladder cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Bladder Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > PKC
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.